Create account

Coverage dated July 5, 2023 to July 6, 2023

The FDA Just Opened Up Access to a Promising New Alzheimer's Drug

Headline from Science Alert

The US drug regulator gave full approval to a new Alzheimer's medicine on Thursday, a move that makes it more widely available to the public through government-run health insurance for the elderly.

Science Alert's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

16 articles, oldest first.

  1. ABC 11 Raleigh

    FDA grants full approval for Alzheimer's drug that has shown to modestly slow cognitive decline (opens ABC 11 Raleigh)

    Published

    ABC 11 Raleigh's feed description

    U.S. officials granted full approval to a closely watched Alzheimer's drug on Thursday, clearing the way for Medicare and other insurance plans to begin covering the treatment.

  2. Roll Call

    Expected Alzheimer’s drug approval signals new era in treatment (opens Roll Call)

    Published

    Roll Call's feed description

    The Alzheimer's drug's approval would trigger broader access under Medicare, but critics say it shouldn't be on the market at all.

  3. WFLA

    Alzheimer’s drug gets full FDA approval; Medicare will pay for it (opens WFLA)

    Published

    WFLA's feed description

    U.S. officials granted full approval to a closely watched Alzheimer’s drug on Thursday, clearing the way for Medicare and other insurance plans to begin covering the treatment for people with the b…

  4. NBC News

    FDA grants full approval to new Alzheimer's drug meant to slow disease (opens NBC News)

    Published

    NBC News's feed description

    Approval will expand access to the drug, which will be covered by Medicare under certain circumstances.

  5. Politico

    FDA grants first full approval for an Alzheimer’s drug in 20 years (opens Politico)

    Published

    Politico's feed description

    Questions linger around how many patients will be able to access the drug with limited coverage from Medicare.

  6. Science Alert

    The FDA Just Opened Up Access to a Promising New Alzheimer's Drug (opens Science Alert)

    Published

    Science Alert's feed description

    The US drug regulator gave full approval to a new Alzheimer's medicine on Thursday, a move that makes it more widely available to the public through government-run health insurance for the elderly.

  7. WMUR

    Alzheimer’s drug has full FDA approval now and that means Medicare will pay for it (opens WMUR)

    Published

    WMUR's feed description

    It’s the first medicine that’s been convincingly shown to modestly slow Alzheimer’s cognitive decline.

  8. MedicalXpress

    US makes new Alzheimer's drug more widely accessible (opens MedicalXpress)

    Published

    MedicalXpress's feed description

    The US drug regulator gave full approval to a new Alzheimer's medicine on Thursday, a move that makes it more widely available to the public through government-run health insurance for the elderly.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

The FDA Just Opened Up Access to a Promising New Alzheimer's Drug | Since Then